Try our Advanced Search for more refined results
August 07, 2018
Amgen Inc. et al v. Accord BioPharma
Case Number:
0:18-cv-61828
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 05, 2019
Apotex Can't Sink Amgen's IP Suit Over Drugs To Aid Chemo
Amgen can move forward with allegations that Apotex infringed a patent covering its chemotherapy-easing drugs Neupogen and Neulasta after a Florida federal judge ruled that it was too early to find the suit was barred by litigation over a related patent.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login